Therapy-related myeloid leukemia (Q28284888)

Hematology / Oncology Clinics of North America

Europe PubMed Central

title

Therapy-related myeloid leukemia (English)

0 references

1 reference

1 reference

M J Thirman

1

0 references

R A Larson

series ordinal

2

0 references

language of work or name

English

0 references

publication date

April 1996

0 references

published in

0 references

volume

10

0 references

issue

2

0 references

page(s)

293-320

0 references

cites work

Implication of prior treatment with drug combinations including inhibitors of topoisomerase II in therapy-related monocytic leukemia with a 9;11 translocation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Increased risk of secondary acute nonlymphocytic leukemia after extended-field radiation therapy combined with MOPP chemotherapy for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Bone marrow transplantation for patients with myelodysplasia. Pretreatment variables and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Acute leukaemia with t(4;11) in patients previously exposed to carcinogens

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Banded chromosome analysis in patients with treatment-associated acute nonlymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

A hematological remission by clonal hematopoiesis after treatment with recombinant human granulocyte-macrophage colony-stimulating factor and erythropoietin in a patient with therapy-related myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Leukemia and Preleukemia after Adjuvant Treatment of Gastrointestinal Cancer with Semustine (Methyl-CCNU)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Partially matched bone marrow transplantation in patients with myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Ultrastructural characterization of de novo and secondary leukemias

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Acute nonlymphocytic leukemia.A delayed complication of Hodgkin's disease therapy: Analysis of 109 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Importance of bone marrow cytogenetic evaluation before autologous bone marrow transplantation for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Second primary malignancy after Hodgkin's disease, ovarian cancer and cancer of the testis: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Acute leukemias of different lineages have similar MLL gene fusions encoding related chimeric proteins resulting from chromosomal translocation.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Leukemia risk following radiotherapy for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Risk of leukemia after chemotherapy and radiation treatment for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Preleukemic changes in cases of nonlymphocytic leukemia secondary to cytotoxic therapy. Analysis of 105 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Leukaemia complicating treatment for Hodgkin's disease: the experience of the British National Lymphoma Investigation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Intensive antileukemic treatment of patients younger than 65 years with myelodysplastic syndromes and secondary acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Allogeneic bone marrow transplantation for secondary leukaemia and myelodysplastic syndrome: a survey by the Leukaemia Working Party of the European Bone Marrow Transplantation Group (EBMTG)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Response of therapy-associated acute nonlymphocytic leukemia to intensive induction chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Myelodysplastic syndrome and acute nonlymphocytic leukemia secondary to mitolactol treatment in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Translocation t(9;11)(p21;q23) with acute myelomonocytic leukemia after chemotherapy for osteosarcoma: good response to antileukemic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Favorable cytogenetic abnormalities in secondary leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Leukemia in breast cancer patients following adjuvant chemotherapy or postoperative radiation: the NSABP experience

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Fourth International Workshop on Chromosomes in Leukemia 1982: Secondary leukemias associated with neoplasia: treated and untreated

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Successful marrow transplantation for acute myelocytic leukemia following therapy for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Acute nonlymphocytic leukemia after therapy with alkylating agents for ovarian cancer: a study of five randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Site of injection and response to hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Melphalan may be a more potent leukemogen than cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Chromosome analysis of 63 cases of secondary nonlymphoid blood disorders: a cooperative study. Groupe Francais de Cytogénétique Hématologique

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Acute leukemia after the treatment of Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

AML associated with previous cytotoxic therapy, MDS or myeloproliferative disorders: results from the MRC's 9th AML trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Cytogenetic and clinical investigations in 76 cases with therapy-related leukemia and myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: an international collaborative study among cancer registries.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Leukemia following Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Treatment of therapy-related leukemia and myelodysplastic syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

The association of specific "favorable" cytogenetic abnormalities with secondary leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Translocations (5;17) and (7;17) in patients with de novo or therapy-related myelodysplastic syndromes or acute nonlymphocytic leukemia. A possible association with acquired pseudo-Pelger-Huët anomaly and small vacuolated granulocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Bone marrow transplantation for myelodysplasia and secondary acute nonlymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Cloning of cDNAs of the MLL gene that detect DNA rearrangements and altered RNA transcripts in human leukemic cells with 11q23 translocations

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Second malignant neoplasms in children: an update from the Late Effects Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Genes on chromosomes 4, 9, and 19 involved in 11q23 abnormalities in acute leukemia share sequence homology and/or common motifs

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agent

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Translocation (3;21)(q26;q22) in therapy-related myelodysplasia following drugs targeting DNA-topoisomerase II combined with alkylating agents, and in myeloproliferative disorders undergoing spontaneous leukemic transformation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Incidence of acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome up to 10 years after treatment of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Two different classes of therapy-related and de-novo acute myeloid leukemia?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome secondary to treatment of other malignant diseases. II. Bone marrow cytology, cytogenetics, results of HLA typing, response to antileukemic chemotherapy, and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Acute monocytic or myelomonocytic leukemia with balanced chromosome translocations to band 11q23 after therapy with 4-epi-doxorubicin and cisplatin or cyclophosphamide for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Risk of therapy-related leukaemia and preleukaemia after Hodgkin's disease. Relation to age, cumulative dose of alkylating agents, and time from chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Therapy of secondary acute nonlymphocytic leukemia with cytarabine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Acute Leukemia after Alkylating-Agent Therapy of Ovarian Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Mapping chromosome band 11q23 in human acute leukemia with biotinylated probes: identification of 11q23 translocation breakpoints with a yeast artificial chromosome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Marrow transplantation for acute nonlymphocytic leukemia following therapy for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Acute lymphoblastic leukaemia with t(4;11) follows neuroblastoma: a late effect of treatment?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

ACUTE MYELOID LEUKAEMIA FOLLOWING INTERFERON-ALFA TREATMENT OF HAIRY CELL LEUKAEMIA

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

der(5)t(5;7)(q11.2;p11.2): A new recurring abnormality in malignant myeloid disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Cloning of ELL, a gene that fuses to MLL in a t(11;19)(q23;p13.1) in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Risk of second cancers after treatment for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Leukemia after therapy with alkylating agents for childhood cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Second acute leukemia and other malignancies following treatment for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Second malignancies after CMF for resectable breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Deletion of 5q by t(5;17) in therapy-related myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Subsequent development of acute non-lymphocytic leukemia in patients treated for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Increased risk of lung cancer, non-Hodgkin's lymphoma, and leukemia following Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Acute nonlymphocytic leukemia in malignant lymphoma.A morphologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Effective chemotherapy of acute myelocytic leukemia occurring after alkylating agent or radiation therapy for prior malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Translocation (9;11)(p21;q23) in a child with acute monoblastic leukemia following 2 1/2 years after successful chemotherapy for neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Specific chromosomal translocations and therapy-related leukemia induced by bimolane therapy for psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021

Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970340-3

7 January 2021